Jupiter Neurosciences, Inc.JUNSNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -709.57% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -819.51% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -814.74% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -814.74% | +0.00% |
| Weighted Average Shares Growth | +17.66% | -2.89% | +0.69% | +0.93% | +9.57% |
| Weighted Average Shares Diluted Growth | +17.66% | -2.89% | +0.69% | +0.93% | +9.57% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +0.00% | +4074.12% | +4148.27% | +2801.70% | +2911.55% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +0.00% | -90.32% | -91.01% | -91.77% | -92.37% |
| R&D Expense Growth | -61.62% | -17.87% | +373.05% | +651.36% | +788.57% |
| SG&A Expenses Growth | -66.60% | +332.21% | +126.95% | +230.14% | +268.58% |